Metformin-Mediated Improvement in Solubility, Stability, and Permeability of Nonsteroidal Anti-Inflammatory Drugs
Pharmaceutics · 11.03.2024 · 16 (3) · 382
DOI: 10.3390/pharmaceutics16030382 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 11.03.2024. Verfasst von Qi An und 10 weiteren Autor:innen. Beteiligte Einrichtung: Beijing City Key Laboratory of Polymorphic Drugs, Center of Pharmaceutical Polymorphs, Institute of Materia Medica, Chinese Academy of Medical Scienc…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences, the Chinese Pharmacopoeia Commission Drug Standard Promoting Fund.
Abstract (Originalsprache)
Nonsteroidal anti-inflammatory drugs (NSAIDs) are class II biopharmaceutics classification system drugs. The poor aqueous solubility of NSAIDs can lead to limited bioavailability after oral administration. Metformin (MET), a small-molecule compound, can be used in crystal engineering to modulate the physicochemical properties of drugs and to improve the bioavailability of orally administered drugs, according to the literature research and preliminary studies. We synthesized two drug–drug molecular salts (ketoprofen–metformin and phenylbutazone–metformin) with NSAIDs and thoroughly characterized them using SCXRD, PXRD, DSC, and IR analysis to improve the poor solubility of NSAIDs. In vitro evaluation studies revealed that the thermal stability and solubility of NSAIDs-MET were substantially enhanced compared with those of NSAIDs alone. Unexpectedly, an additional increase in permeability was observed. Since the structure determines the properties, the structure was analyzed using theoretical calculations to reveal the intermolecular interactions and to explain the reason for the change in properties. The salt formation of NSAIDs with MET could substantially increase the bio-absorption rate of NSAIDs, according to the in vivo pharmacokinetic findings, which provides an experimental basis for developing new antipyretic and analgesic drugs with rapid onset of action.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Beijing City Key Laboratory of Polymorphic Drugs, Center of Pharmaceutical Polymorphs, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
- Beijing Key Laboratory of Drug Targets Identification and Drug Screening, National Center for Pharmaceutical Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College,…
ORCID-Profile: Shiying Yang, Dezhi Yang
Förderung
- National Natural Science Foundation of China
- CAMS Innovation Fund for Medical Sciences
- the Chinese Pharmacopoeia Commission Drug Standard Promoting Fund
- Chinese Pharmacopoeia Commission Drug Standard Promoting Fund
Zitieren
APA
An, Q., Xing, C., Wang, Z., Li, S., Wang, W., Yang, S., Kong, L., Yang, D., Zhang, L., Du, G., & Lu, Y. (2024). Metformin-Mediated Improvement in Solubility, Stability, and Permeability of Nonsteroidal Anti-Inflammatory Drugs. Pharmaceutics, 16(3), 382. https://doi.org/10.3390/pharmaceutics16030382
Vancouver
An Q, Xing C, Wang Z, Li S, Wang W, Yang S, et al. Metformin-Mediated Improvement in Solubility, Stability, and Permeability of Nonsteroidal Anti-Inflammatory Drugs. Pharmaceutics. 2024;16(3):382. doi:10.3390/pharmaceutics16030382
BibTeX
@article{An2024,
author = {An, Qi and Xing, Cheng and Wang, Zhipeng and Li, Shuang and Wang, Wenwen and Yang, Shiying and Kong, Linglei and Yang, Dezhi and Zhang, Li and Du, Guanhua and Lu, Yang},
title = {Metformin-Mediated Improvement in Solubility, Stability, and Permeability of Nonsteroidal Anti-Inflammatory Drugs},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {3},
pages = {382},
doi = {10.3390/pharmaceutics16030382}
}
EUVIMED